Elisabeth A. Bone
Impact in
- Cancer Research top 2%
- Protease and Inhibitor Mechanisms
- Immunology and Allergy top 5%
- Cell Adhesion Molecules Research
Papers in
-
- Histone Deacetylase Inhibitors Research 4
- Oncology 10
- Peptidase Inhibition and Analysis 8
- Co-authors
- Robert H. Michell (4 shared papers)Susan Palmer (3 shared papers)Pamela Fretten (2 shared papers)Peter de Nully Brown (3 shared papers)A. J. H. Gearing (1 shared paper)Stephen Chandler (1 shared paper)Graham Wells (1 shared paper)C J Kirk (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (2 papers)Biochemical Society Transactions (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Biochemical Journal (2 papers)British Journal of Cancer (2 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Elisabeth A. Bone
31 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 99
- Cancer Research 660
- Immunology and Allergy 137
- Oncology 570
- Hematology 216
- Cellular and Molecular Neuroscience 218
Countries citing papers authored by Elisabeth A. Bone
This map shows the geographic impact of Elisabeth A. Bone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth A. Bone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth A. Bone more than expected).
Fields of papers citing papers by Elisabeth A. Bone
This network shows the impact of papers produced by Elisabeth A. Bone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth A. Bone. The network helps show where Elisabeth A. Bone may publish in the future.
Co-authors
The 25 scholars most cited alongside Elisabeth A. Bone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 253 | |
| 2 | 1984 | 205 | |
| 3 | 1999 | 180 | |
| 4 | 1995 | 160 | |
| 5 | Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94). | 1996 | 155 |
| 6 | 1984 | 114 | |
| 7 | Batimastat, a synthetic inhibitor of matrix metalloproteinases, potentiates the antitumor activity of cisplatin in ovarian carcinoma xenografts. | 1998 | 74 |
| 8 | 1986 | 74 | |
| 9 | The matrix metalloproteinase inhibitor batimastat (BB-94) retards human breast cancer solid tumor growth but not ascites formation in nude mice. | 1996 | 73 |
| 10 | 2010 | 68 | |
| 11 | 2010 | 60 | |
| 12 | 2021 | 47 | |
| 13 | 1999 | 47 | |
| 14 | 2001 | 45 | |
| 15 | 1985 | 41 | |
| 16 | 1988 | 27 | |
| 17 | 1984 | 26 | |
| 18 | 1986 | 25 | |
| 19 | 2010 | 22 | |
| 20 | 1997 | 22 |
About Elisabeth A. Bone
Elisabeth A. Bone is a scholar working on Molecular Biology, Oncology, Cancer Research, Hematology and Endocrinology, Diabetes and Metabolism, having authored 32 papers that have together received 1.8k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (9 papers), Peptidase Inhibition and Analysis (8 papers), Histone Deacetylase Inhibitors Research (4 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers), Neuropeptides and Animal Physiology (4 papers), Neuroendocrine regulation and behavior (3 papers), Thyroid Disorders and Treatments (3 papers) and Platelet Disorders and Treatments (3 papers). The work is most often cited by research in Cancer Research (660 citations), Immunology and Allergy (137 citations), Oncology (570 citations), Hematology (216 citations) and Cellular and Molecular Neuroscience (218 citations). Elisabeth A. Bone has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Robert H. Michell, Susan Palmer, Pamela Fretten, Peter de Nully Brown, A. J. H. Gearing, Stephen Chandler, Graham Wells, C J Kirk, R. Fife and G. W. Sledge. Their work appears in journals such as Journal of Medicinal Chemistry, Biochemical Society Transactions, Bioorganic & Medicinal Chemistry Letters, Biochemical Journal and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.